Handelsbanken Fonder Ab 10x Genomics, Inc. Transaction History

Handelsbanken Fonder Ab

$26.2 Billion
Q4 2024

A detailed history of Handelsbanken Fonder Ab transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 35,200 shares of TXG stock, worth $416,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,200

Previous 28,200 24.82%

Holding current value

$416,064

Previous $637,000 20.72%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$13.18 - $21.31 $92,260 - $149,170	7,000 Added 24.82%	35,200 $505,000
Q3 2024 Oct 04, 2024	BUY	$15.71 - $23.49 $64,411 - $96,309	4,100 Added 17.01%	28,200 $637,000
Q2 2024 Aug 05, 2024	BUY	$19.45 - $37.37 $89,470 - $171,902	4,600 Added 23.59%	24,100 $469,000
Q1 2024 May 13, 2024	BUY	$36.08 - $54.3 $703,560 - $1.06 Million	19,500 New	19,500 $732,000
Q2 2023 Aug 02, 2023	BUY	$50.96 - $58.72 $30,576 - $35,232	600 Added 4.2%	14,900 $832,000
Q2 2022 Aug 03, 2022	BUY	$36.95 - $82.41 $45,005 - $100,375	1,218 Added 9.31%	14,300 $647,000
Q1 2022 May 11, 2022	BUY	$55.7 - $145.79 $50,130 - $131,211	900 Added 7.39%	13,082 $995,000
Q4 2021 Feb 08, 2022	BUY	$135.05 - $182.59 $634,464 - $857,807	4,698 Added 62.77%	12,182 $1.82 Million
Q2 2021 Aug 03, 2021	SELL	$134.22 - $202.37 $700,091 - $1.06 Million	-5,216 Reduced 41.07%	7,484 $1.47 Million
Q1 2021 Apr 29, 2021	SELL	$140.25 - $196.86 $140,250 - $196,860	-1,000 Reduced 7.3%	12,700 $2.3 Million
Q4 2020 Feb 11, 2021	BUY	$126.47 - $163.7 $1.73 Million - $2.24 Million	13,700 New	13,700 $1.94 Million

Others Institutions Holding TXG

# of Institutions

295

Shares Held

97.1M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.12B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab 10x Genomics, Inc. Transaction History